24 October 2025
: Case report 
Medical Management of an Infusion Site Extravasation Injury After Peripheral Intravenous Infusion of Ado-Trastuzumab Emtansine in a 38-Year-Old Woman With Breast Cancer: A Case Report
Unusual clinical course, Adverse events of drug therapy
Eleni M. Gamvroulas BDEF 1*, Patricia Jeppson E 1, Mei Wei
ADEF 2
DOI: 10.12659/AJCR.949828
Am J Case Rep 2025; 26:e949828
Figure 4 A 38-year-old woman with infusion site extravasation injury following intravenous treatment with TDM1. At 14 days after initial insult, her erythema is beginning to resolve and swelling is much improved. No blisters remain and most of that tissue is removed. She has begun to scab over her open wounds.